TGF-β-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen

Journal of Cell Science

Volumn 118, Issue 19, 2005, Pages 4577-4586

  Leksa, Vladimír ^a,b   Godar, Samuel ^c   Schiller, Herbert B ^a   Fuertbauer, Elke ^c   Muhammad, Arshad ^c   Slezakova, Katarina ^b   Horejsi, Vaclav ^d   Steinlein, Peter ^e   Weidle, Ulrich H ^f   Binder, Bernd R ^c   Stockinger, Hannes ^a,c  

^a BMT Research   (Austria)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^e RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^f ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Angiogenesis; Apoptosis; Fibrinolysis; Mini plasminogen; TGF

Indexed keywords

PLASMINOGEN; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UROKINASE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DENSITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR AFFINITY; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURFACE PLASMON RESONANCE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEIN ISOFORMS; RECEPTOR, IGF TYPE 2; RECEPTORS, CELL SURFACE; SURFACE PLASMON RESONANCE; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 27644479266     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02587     Document Type: Article

References (61)

1. Boehme, M. W., Galle, P. and Stremmel, W. (2002). Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107, 340-349.
2. Booyse, F. M., Lin, P. H., Traylor, M. and Bruce, R. (1988). Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells. J. Biol. Chem. 263, 15139-15145.
3. Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D. and Ruoslahti, E. (1992). Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360, 361-364.
4. Brown, P. D., Wakefield, L. M., Levinson, A. D. and Sporn, M. B. (1990). Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3, 35-43.
5. Bykowska, K., Levin, E. G., Rijken, D. C., Loskutoff, D. J. and Collen, D. (1982). Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. Biochim. Biophys. Acta 703, 113-115.
6. Camoin, L., Pannell, R., Anfosso, F., Lefevre, J. P., Sampol, J., Gurewich, V. and Dignat-George, F. (1998). Evidence for the expression of urokinase-type plasminogen activator by human venous endothelial cells in vivo. Thromb. Haemost. 80, 961-967.
7. Cao, Y., Chen, A., An, S. S., Ji, R. W., Davidson, D. and Llinas, M. (1997). Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928.
8. Cao, Y., O'Reilly, M. S., Marshall, B., Flynn, E., Ji, R. W. and Folkman, J. (1998). Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101, 1055-1063.
9. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
10. Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A. and Shapiro, S. D. (1998). Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161, 6845-6852.
11. Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M., Lawler, J., Hynes, R. O., Boivin, G. P. and Bouck, N. (1998). Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93, 1159-1170.
12. Dhanabal, M., Ramchandran, R., Waterman, M. J., Lu, H., Knebelmann, B., Segal, M. and Sukhatme, V. P. (1999). Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726.
13. Fajardo, L. F., Prionas, S. D., Kwan, H. H., Kowalski, J. and Allison, A. C. (1996). Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern. Lab. Invest. 74, 600-608.
14. Falcone, D. J., Khan, K. M., Layne, T. and Fernandes, L. (1998). Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. J. Biol. Chem. 273, 31480-31485.
15. Folkman, J. and D'Amore, P. A. (1996). Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155.
16. Gajdusek, C. M., Luo, Z. and Mayberg, M. R. (1993). Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J. Cell Physiol. 157, 133-144.
17. Ghosh, P., Dahms, N. M. and Kornfeld, S. (2003). Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 4, 202-212.
18. Godar, S., Horejsi, V., Weidle, U. H., Binder, B. R., Hansmann, C. and Stockinger, H. (1999). M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur. J. Immunol. 29, 1004-1013.
19. Gonzalez-Gronow, M., Kalfa, T., Johnson, C. E., Gawdi, G. and Pizzo, S. V. (2003). The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J. Biol. Chem. 278, 27312-27318.
20. Hirschi, K. K., Rohovsky, S. A. and D'Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141, 805-814.
21. Iruela-Arispe, M. L. and Sage, E. H. (1993). Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1. J. Cell Biochem. 52, 414-430.
22. Jackson, C. (2002). Matrix metalloproteinases and angiogenesis. Curr. Opin. Nephrol. Hypertens. 11, 295-299.
23. Koh, G. Y., Kim, S. J., Klug, M. G., Park, K., Soonpaa, M. H. and Field, L. J. (1995). Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J. Clin. Invest. 95, 114-121.
24. Kroismayr, R., Baranyi, U., Stehlik, C., Dorfleutner, A., Binder, B. R. and Lipp, J. (2004). HERC5, a HECT E3 ubiquitin ligase tightly regulated in LPS activated endothelial cells. J. Cell Sci. 117, 4749-4756.
25. Leksa, V., Godar, S., Cebecauer, M., Hilgert, I., Breuss, J., Weidle, U. H., Horejsi, V., Binder, B. R. and Stockinger, H. (2002). The N-terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration. J. Biol. Chem. 277, 40575-40582.
26. Lijnen, H. R., Van Hoef, B., Ugwu, F., Collen, D. and Roelants, I. (2000). Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium sp. Biochemistry 39, 479-488.
27. Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandriota, S. J., Borlat, F., Sim, B. K., Wu, Z., Grau, G. E., Shing, Y. et al. (1998). Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 92, 4730-4741.
28. Lyons, R. M., Gentry, L. E., Purchio, A. F. and Moses, H. L. (1990). Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110, 1361-1367.
29. Machovich, R. and Owen, W. G. (1989). An elastase-dependent pathway of plasminogen activation. Biochemistry 28, 4517-4522.
30. Madri, J. A., Bell, L. and Merwin, J. R. (1992). Modulation of vascular cell behavior by transforming growth factors beta. Mol. Reprod. Dev. 32, 121-126.
31. Morikawa, W., Yamamoto, K., Ishikawa, S., Takemoto, S., Ono, M., Fukushi, J., Naito, S., Nozaki, C., Iwanaga, S. and Kuwano, M. (2000). Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J. Biol. Chem. 275, 38912-38920.
32. Moroz, L. A. (1981). Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase. Blood 58, 97-104.
33. Moser, T. L., Stack, M. S., Asplin, I., Enghild, J. J., Hojrup, P., Everitt, L., Hubchak, S., Schnaper, H. W. and Pizzo, S. V. (1999). Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. USA 96, 2811-2816.
34. Moses, H. L., Yang, E. Y. and Pietenpol, J. A. (1990). TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247.
35. Motyka, B., Korbutt, G., Pinkoski, M. J., Heibein, J. A., Caputo, A., Hobman, M., Barry, M., Shostak, I., Sawchuk, T., Holmes, C. F. et al. (2000). Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103, 491-500.
36. Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., Dalton, S. L., Wu, J., Pittet, J. F., Kaminski, N., Garat, C., Matthay, M. A. et al. (1999). The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328.
37. Nunes, I., Shapiro, R. L. and Rifkin, D. B. (1995). Characterization of latent TGF-beta activation by murine peritoneal macrophages. J. Immunol. 155, 1450-1459.
38. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. and Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
39. Pepper, M. S. (2001). Extracellular proteolysis and angiogenesis. Thromb. Haemost. 86, 346-355.
40. Plouet, J. and Gospodarowicz, D. (1989). Transforming growth factor beta1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells. J. Cell Physiol. 141, 392-399.
41. Pollanen, J., Stephens, R. W. and Vaheri, A. (1991). Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res. 57, 273-328.
42. Pollman, M. J., Naumovski, L. and Gibbons, G. H. (1999). Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99, 2019-2026.
43. Prager, G. W., Breuss, J. M., Steurer, S., Mihaly, J. and Binder, B. R. (2004). Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood 103, 955-962.
44. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
45. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H. et al. (1986). Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167-4171.
46. Saksela, O., Moscatelli, D. and Rifkin, D. B. (1987). The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol. 105, 957-963.
47. Sato, Y., Tsuboi, R., Lyons, R., Moses, H. and Rifkin, D. B. (1990). Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111, 757-763.
48. Sawdey, M., Podor, T. J. and Loskutoff, D. J. (1989). Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J. Biol. Chem. 264, 10396-10401.
49. Scapini, P., Nesi, L., Morini, M., Tanghetti, E., Belleri, M., Noonan, D., Presta, M., Albini, A. and Cassatella, M. A. (2002). Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J. Immunol. 168, 5798-5804.
50. Schulick, A. H., Taylor, A. J., Zuo, W., Qiu, C. B., Dong, G., Woodward, R. N., Agah, R., Roberts, A. B., Virmani, R. and Dichek, D. A. (1998). Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc. Natl. Acad. Sci. USA 95, 6983-6988.
51. Soff, G. A. (2000). Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev. 19, 97-107.
52. Sottrup-Jensen, L., Claeys, H., Zajdel, M., Petersen, T. E. and Magnusson, S. (1978). The primary structure of human plasminogen: isolation of two lysine-binding fragments and one 'mini'-plasminogen (Mw, 38,000) by elastase-catalyzed-specific limited proteolysis. In Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3 (ed. J. F. Davidson, R. M. Rowan, M. M. Samama and P. C. Desnoyers), pp. 191-209. New York: Raven Press.
53. Stepanova, V. V. and Tkachuk, V. A. (2002). Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry 67, 109-118.
54. Takahashi, K., Kiguchi, T., Sawasaki, Y., Karikusa, F., Nemoto, N., Matsuoka, T. and Yamamoto, M. (1992). Lung capillary endothelial cells produce and secrete urokinase-type plasminogen activator. Am. J. Respir. Cell Mol. Biol. 7, 90-94.
55. Tarui, T., Miles, L. A. and Takada, Y. (2001). Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276, 39562-39568.
56. Tarui, T., Majumdar, M., Miles, L. A., Ruf, W. and Takada, Y. (2002). Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J. Biol. Chem. 277, 33564-33570.
57. Tkachuk, V., Stepanova, V., Little, P. J. and Bobik, A. (1996). Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin. Exp. Pharmacol. Physiol. 23, 759-765.
58. van Hinsbergh, V. W., Binnema, D., Scheffer, M. A., Sprengers, E. D., Kooistra, T. and Rijken, D. C. (1987). Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis 7, 389-400.
59. Vernon, R. B. and Sage, E. H. (1999). A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc. Res. 57, 118-133.
60. Wajih, N. and Sane, D. C. (2003). Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Blood 101, 1857-1863.
61. Yang, J. J., Kettritz, R., Falk, R. J., Jeanette, J. C. and Gaido, M. L. (1996). Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am. J. Pathol. 149, 1617-1626.